Qinglan Guo

2.1k total citations
57 papers, 1.6k citations indexed

About

Qinglan Guo is a scholar working on Molecular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, Qinglan Guo has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Medicine, 20 papers in Epidemiology and 18 papers in Pharmacology. Recurrent topics in Qinglan Guo's work include Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Pneumonia and Respiratory Infections (11 papers). Qinglan Guo is often cited by papers focused on Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Pneumonia and Respiratory Infections (11 papers). Qinglan Guo collaborates with scholars based in China, United States and United Kingdom. Qinglan Guo's co-authors include Minggui Wang, Xiaogang Xu, Xinyu Ye, Minghua Wang, David C. Hooper, Xiaoying Wang, Shi Wu, Yohei Doi, Fupin Hu and Christi L. McElheny and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Qinglan Guo

57 papers receiving 1.6k citations

Peers

Qinglan Guo
Abiola Olumuyiwa Olaitan France
María‐Isabel Morosini Spain
Qiwen Yang China
Mikhail V. Edelstein Russia
Michael Hornsey United Kingdom
Eun-Jeong Yoon South Korea
Frank Hansen Denmark
Jun-ichi Wachino Japan
Lingbin Shu China
Alain A. Ocampo-Sosa Spain
Abiola Olumuyiwa Olaitan France
Qinglan Guo
Citations per year, relative to Qinglan Guo Qinglan Guo (= 1×) peers Abiola Olumuyiwa Olaitan

Countries citing papers authored by Qinglan Guo

Since Specialization
Citations

This map shows the geographic impact of Qinglan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglan Guo more than expected).

Fields of papers citing papers by Qinglan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglan Guo. The network helps show where Qinglan Guo may publish in the future.

Co-authorship network of co-authors of Qinglan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglan Guo. A scholar is included among the top collaborators of Qinglan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglan Guo. Qinglan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Leilei, et al.. (2023). Insertion of IS Pa1635 in IS CR1 Creates a Hybrid Promoter for bla PER-1 Resulting in Resistance to Novel β-lactam/β-lactamase Inhibitor Combinations and Cefiderocol. Antimicrobial Agents and Chemotherapy. 67(6). e0013523–e0013523. 5 indexed citations
3.
Wang, Leilei, et al.. (2023). Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa. Microbiology Spectrum. 11(3). e0093223–e0093223. 3 indexed citations
4.
Hu, Yiyi, Jianping Jiang, Dongliang Wang, Qinglan Guo, & Minggui Wang. (2023). Coexistence of blaKPC-IncFII plasmids and type I-E* CRISPR-Cas systems in ST15 Klebsiella pneumoniae. Frontiers in Microbiology. 14. 1125531–1125531. 10 indexed citations
5.
Chen, Mingliang, et al.. (2023). Penicillin and Cefotaxime Resistance of Quinolone-Resistant Neisseria meningitidis Clonal Complex 4821, Shanghai, China, 1965–2020. Emerging infectious diseases. 29(2). 341–350. 9 indexed citations
6.
Chen, Mingliang, Dan Li, Xiaoying Yang, et al.. (2022). Serogroup Y Clonal Complex 23 Meningococcus in China Acquiring Penicillin Resistance from Commensal Neisseria lactamica Species. Antimicrobial Agents and Chemotherapy. 66(6). e0238321–e0238321. 3 indexed citations
7.
Khurshid, Mohsin, Muhammad Hidayat Rasool, Usman Ali Ashfaq, et al.. (2020). Dissemination of blaOXA-23-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan. Journal of Global Antimicrobial Resistance. 21. 357–362. 34 indexed citations
8.
Khurshid, Mohsin, Muhammad Hidayat Rasool, Usman Ali Ashfaq, et al.. (2020). <p><em>Acinetobacter baumannii</em> Sequence Types Harboring Genes Encoding Aminoglycoside Modifying Enzymes and 16SrRNA Methylase; a Multicenter Study from Pakistan</p>. Infection and Drug Resistance. Volume 13. 2855–2862. 19 indexed citations
9.
Xu, Qingqing, Zi-Ke Sheng, Min Hao, et al.. (2020). RamA upregulates multidrug resistance efflux pumps AcrAB and OqxAB in Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 57(2). 106251–106251. 39 indexed citations
10.
11.
Shen, Zhen, Baixing Ding, Meiping Ye, et al.. (2017). High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 72(7). 1930–1936. 75 indexed citations
12.
Guo, Qinglan, et al.. (2016). Comparative analysis of an IncR plasmid carryingarmA,blaDHA-1andqnrB4fromKlebsiella pneumoniaeST37 isolates. Journal of Antimicrobial Chemotherapy. 71(4). 882–886. 33 indexed citations
13.
Ding, Baixing, Zhen Shen, Fupin Hu, et al.. (2016). In vivo Acquisition of Carbapenemase Gene blaKPC-2 in Multiple Species of Enterobacteriaceae through Horizontal Transfer of Insertion Sequence or Plasmid. Frontiers in Microbiology. 7. 1651–1651. 10 indexed citations
14.
Guo, Qinglan, Christi L. McElheny, Vaughn S. Cooper, et al.. (2016). Glutathione-S-transferase FosA6 ofKlebsiella pneumoniaeorigin conferring fosfomycin resistance in ESBL-producingEscherichia coli. Journal of Antimicrobial Chemotherapy. 71(9). 2460–2465. 50 indexed citations
15.
Sheng, Zi-Ke, Weixia Wang, Qinglan Guo, et al.. (2015). Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline. Journal of Microbiology Immunology and Infection. 49(6). 962–968. 5 indexed citations
16.
Guo, Qinglan, et al.. (2014). Type II and type IV topoisomerase mutations in clinical isolates of Morganella morganii harbouring the qnrD gene. Annals of Clinical Microbiology and Antimicrobials. 13(1). 34–34. 16 indexed citations
17.
Xu, Xiaogang, Chunhui Chen, Dongfang Lin, et al.. (2013). The Fosfomycin Resistance Gene fosB3 Is Located on a Transferable, Extrachromosomal Circular Intermediate in Clinical Enterococcus faecium Isolates. PLoS ONE. 8(10). e78106–e78106. 29 indexed citations
18.
Xu, Xiaogang, Qinglan Guo, Xu Zhao, et al.. (2012). Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates. Journal of Antimicrobial Chemotherapy. 67(7). 1655–1659. 85 indexed citations
19.
Guo, Qinglan, Jingwei Weng, Xiaogang Xu, et al.. (2010). A mutational analysis and molecular dynamics simulation of quinolone resistance proteins QnrA1 and QnrC from Proteus mirabilis. BMC Structural Biology. 10(1). 33–33. 13 indexed citations
20.
Wang, Minghua, Qinglan Guo, Xiaogang Xu, et al.. (2009). New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilis. Antimicrobial Agents and Chemotherapy. 53(5). 1892–1897. 270 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abiola Olumuyiwa Olaitan Breakdown of academic impact, for papers by María‐Isabel Morosini Breakdown of academic impact, for papers by Qiwen Yang Breakdown of academic impact, for papers by Mikhail V. Edelstein Breakdown of academic impact, for papers by Michael Hornsey Breakdown of academic impact, for papers by Eun-Jeong Yoon Breakdown of academic impact, for papers by Frank Hansen Breakdown of academic impact, for papers by Jun-ichi Wachino Breakdown of academic impact, for papers by Lingbin Shu Breakdown of academic impact, for papers by Alain A. Ocampo-Sosa
Rankless by CCL
2026